{"gene":"NKX2-3","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1999,"finding":"Targeted inactivation of Nkx2-3 in mice causes delayed villus formation in small intestine due to reduced epithelial proliferation, and reduced BMP-2 and BMP-4 expression in gut mesenchyme, suggesting non-cell-autonomous control of intestinal cell growth through BMP signaling downstream of Nkx2-3.","method":"Targeted gene knockout in mice with histological and molecular phenotyping (RT-PCR for BMP-2/4), and observation of intestinal and splenic defects","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and molecular phenotype, replicated across multiple labs","pmids":["10207146"],"is_preprint":false},{"year":2000,"finding":"NKX2-3 directly activates MAdCAM-1 transcription in spleen and mucosa-associated lymphoid tissue endothelial cells; NKX2-3-deficient mice completely lack MAdCAM-1, and this loss is responsible for the migration and homing defects of lymphocytes and macrophages.","method":"Targeted gene knockout in mice, immunohistochemistry, RT-PCR, transcriptional activation assay (direct activation of MAdCAM-1 promoter by NKX2-3)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — KO phenotype combined with direct promoter activation assay, replicated in independent lab (PMID:10926756)","pmids":["10790368","10926756"],"is_preprint":false},{"year":2000,"finding":"Nkx2-3, expressed in visceral mesoderm, controls regional expression of MAdCAM-1 in specialized endothelial cells; loss of Nkx2-3 leads to down-regulation of MAdCAM-1 in endothelial cells where Nkx2-3 is normally expressed, impairing leukocyte homing via L-selectin and α4β7 integrin.","method":"Targeted gene knockout, semiquantitative RT-PCR, immunohistochemistry of MAdCAM-1 in Nkx2-3-deficient mice","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — KO with direct molecular readout, independently replicated","pmids":["10926756"],"is_preprint":false},{"year":2003,"finding":"The splenic architectural defects and absence of marginal zone B cells in Nkx2-3-deficient mice are of stromal (non-hematopoietic) origin, as shown by bone marrow reconstitution studies, establishing that Nkx2-3 functions in stromal cells to support correct lymphocyte-stroma interactions.","method":"Bone marrow reconstitution (transplantation) experiments in Nkx2-3-/- mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — epistatic bone marrow reconstitution directly demonstrating stromal vs hematopoietic cell-autonomous function","pmids":["12682228"],"is_preprint":false},{"year":2007,"finding":"Nkx2-3 deficiency causes complex organizational defects in white pulp fibroblast subsets in the spleen, including distributional abnormalities and absence of a complementary fibroblast subpopulation, indicating Nkx2-3 controls fibroblast ontogeny in a tissue-specific manner.","method":"Immunohistochemistry and dual-label immunofluorescence in Nkx2-3-deficient mice","journal":"Pathology oncology research","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, immunohistochemistry without functional rescue","pmids":["17922052"],"is_preprint":false},{"year":2007,"finding":"The splenic vasculature patterning is controlled by two distinct pathways: lymphotoxin-β receptor signaling controls marginal sinus maturation, while Nkx2.3 transcription factor controls vascular compartmentalization of the red pulp and marginal sinus integrity.","method":"Immunohistochemistry in Nkx2-3-deficient mice, LTβR-Ig fusion protein blockade, and genetic deletion of LTβR/RelB/p52","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with multiple knockouts, single lab","pmids":["17318587"],"is_preprint":false},{"year":2011,"finding":"In the absence of Nkx2-3, the spleen develops a peripheral lymph node-like vascular identity, including formation of high endothelial venules (HEVs) expressing PNAd addressin and CCL21, replacing MAdCAM-1; this vascular reprogramming is dependent on lymphotoxin-β receptor signaling and mature T and B cells, impairs lymphocyte recirculation and blood-borne pathogen uptake.","method":"Comparative mRNA expression profiling, immunohistochemistry, adoptive lymphocyte transfer, functional blocking experiments in Nkx2-3-deficient mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, direct functional consequence of vascular identity switch demonstrated","pmids":["21593383"],"is_preprint":false},{"year":2011,"finding":"Nkx2-3 deficiency in the spleen leads to formation of LYVE-1-positive endothelial cysts without true lymphatic commitment (lacking VEGFR-3 and Prox1), indicating that Nkx2-3 normally suppresses this aberrant endothelial differentiation program.","method":"Immunohistochemistry, real-time quantitative PCR, short-term lymphocyte cell-tracing in Nkx2-3-deficient mice","journal":"The journal of histochemistry and cytochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — KO with molecular markers and functional tracing, single lab","pmids":["21705651"],"is_preprint":false},{"year":2011,"finding":"NKX2-3 regulates endothelin-1 (EDN1) and VEGF-PI3K/AKT-eNOS signaling pathways in human intestinal microvascular endothelial cells (HIMECs), with NKX2-3 knockdown reducing VEGF/PI3K/AKT/eNOS expression and increasing EDN1, as validated by cDNA microarray and RT-PCR.","method":"shRNA knockdown in HIMEC lines, cDNA microarray, RT-PCR validation, pathway analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — KD with multiple transcriptional readouts, two HIMEC lines, moderate evidence","pmids":["21637825"],"is_preprint":false},{"year":2011,"finding":"NFAT1 differentially binds to the NKX2-3 promoter region containing rs11190140 SNP, with higher binding to non-methylated and methylated C allele than to T allele, as confirmed by biotin-oligonucleotide pulldown and ChIP assay, suggesting NFAT1 regulates NKX2-3 expression.","method":"Biotin-labeled oligonucleotide pulldown with nuclear extracts, Western blot, ChIP assay","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay and ChIP confirmation, single lab","pmids":["21803625"],"is_preprint":false},{"year":2012,"finding":"NKX2-3 positively regulates PTPN2 expression in B cells and intestinal microvascular endothelial cells; NKX2-3 knockdown reduces PTPN2 mRNA, and mRNA expression of PTPN2 and NKX2-3 are positively correlated in CD patients.","method":"siRNA knockdown, cDNA microarray, RT-PCR validation in B cells and HIMECs","journal":"Disease markers","confidence":"Medium","confidence_rationale":"Tier 3 — KD with transcriptional readout, correlation confirmed in patient samples, single lab","pmids":["22377701"],"is_preprint":false},{"year":2014,"finding":"Nkx2-3 controls the addressin balance in high endothelial venules of Peyer's patches by maintaining MAdCAM-1 expression; in Nkx2-3-deficient mice, MAdCAM-1 is replaced by PNAd (peripheral node addressin) in an LTβR- and lymphocyte-dependent manner, while general HEV functionality for lymphocyte homing is preserved.","method":"Immunofluorescence, flow cytometry, in vivo MECA-79 blocking, quantitative PCR in Nkx2-3-deficient mice","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods including in vivo functional blocking, single lab","pmids":["25320278"],"is_preprint":false},{"year":2016,"finding":"NKX2-3 promotes marginal-zone lymphomagenesis by inducing B-cell receptor signaling through phosphorylation of Lyn/Syk kinases, which activate integrins (LFA-1, VLA-4), adhesion molecules (ICAM-1, MAdCAM-1), and CXCR4, ultimately triggering NF-κB and PI3K-AKT pathways; transgenic NKX2-3 overexpression in B cells is sufficient to drive marginal-zone expansion and lymphoma development.","method":"Transgenic mouse model (NKX2-3 overexpression in B cells), Nkx2-3-deficient mice, phosphorylation assays, functional migration/homing assays, signaling pathway analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — transgenic overexpression + KO genetic model + biochemical signaling assays, multiple orthogonal methods","pmids":["27297662"],"is_preprint":false},{"year":2018,"finding":"NKX2-3 is a target of EDA/EDAR signaling in the enamel knot; NKX2-3 mediates p21 expression, activates BMP signaling by upregulating Bmp2 and Bmpr2 in dental epithelium, and decreases SOX2 expression, establishing an EDA→NKX2-3→p21/BMP2/BMPR2 pathway required for enamel knot formation and cusp morphogenesis.","method":"Gene microarray in mouse embryos, EDA signaling assays, immunostaining, Nkx2-3-deficient mouse phenotyping","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placed by microarray + KO + upstream signaling assay, single lab","pmids":["30089653"],"is_preprint":false},{"year":2019,"finding":"BMP2b from pharyngeal ectoderm activates Smad effectors in endodermal cells to induce nkx2.3-positive pharyngeal pouch progenitors in zebrafish; BMP signaling is required for specification of these nkx2.3+ progenitors, which give rise to the pouch epithelium.","method":"Cell lineage tracing, transgenic ablation, chemical inhibitor screen, loss-of-function analyses, Smad effector assays in zebrafish","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis and lineage tracing in zebrafish ortholog, multiple methods","pmids":["30763319"],"is_preprint":false},{"year":2019,"finding":"Nkx2.3 expression is restricted to VAP-1+ myofibroblast-like pericryptal stromal cells in the colon; Nkx2.3-/- hematopoietic cells cannot rescue wild-type mice from colitis, whereas absence of Nkx2.3 in stromal cells attenuates DSS-induced colitis and enhances colonic epithelial regeneration, placing Nkx2.3 in stromal cells as a driver of colitis.","method":"LacZ-Nkx2.3 reporter mice, bone marrow transplantation rescue experiments, DSS colitis model, flow cytometry, quantitative PCR","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous localization by reporter, bone marrow rescue epistasis, direct functional colitis phenotype","pmids":["30700585"],"is_preprint":false},{"year":2019,"finding":"A nonsense mutation in NKX2-3 cosegregates with familial idiopathic intestinal varices in a four-generation human pedigree (LOD score 3.3), linking NKX2-3 loss-of-function to intestinal vascular development in humans, consistent with the molecular pathway established in mice.","method":"Whole-exome sequencing, targeted Sanger sequencing, linkage analysis (LOD score)","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — human genetics with strong LOD score linking NKX2-3 loss-of-function to vascular phenotype consistent with mouse data","pmids":["31498527"],"is_preprint":false},{"year":2020,"finding":"Nkx2-3 inhibits proliferation and migration of vascular smooth muscle cells (VSMCs) by promoting autophagy through activation of the AMPK/mTOR signaling pathway; autophagy inhibition with 3-MA abolished the inhibitory effects of Nkx2-3 on VSMC proliferation and migration both in vivo and in vitro.","method":"Adenovirus-mediated overexpression and siRNA knockdown, carotid balloon injury model, EdU/CCK-8 proliferation assays, scratch migration assay, fluorescent mRFP-GFP-LC3 autophagy assay, transmission electron microscopy, AMPK/mTOR pathway inhibitor rescue","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with pharmacological rescue, in vivo and in vitro, single lab","pmids":["33928642"],"is_preprint":false},{"year":2021,"finding":"Aberrantly expressed NKX2-3 in a megakaryoblastic AML cell line (ELF-153) activates FLI1, a master factor for myelopoiesis driving megakaryocytic differentiation and suppressing erythroid differentiation, implicating NKX2-3 as an oncogenic driver of specific AML subtypes through FLI1 regulation.","method":"Comparative expression profiling, siRNA knockdown experiments in AML cell lines","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 3 — siRNA KD with transcriptional readout, single lab, consistent with AML patient data","pmids":["34768865"],"is_preprint":false},{"year":2023,"finding":"In the absence of Nkx2-3, the spleen develops ectopic Prox1-positive lymphatic capillaries (gp38/CD31 double-positive lymphatic endothelial cells) and loses Clever1-positive venous red pulp segments, resulting in impaired splenic erythropoiesis and severely reduced megakaryocyte colony formation after Romiplostim stimulation.","method":"Immunofluorescence, flow cytometry, quantitative PCR, pharmacological stimulation (Romiplostim/thrombopoietin-receptor mimetic) in Nkx2-3-deficient mice","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with multiple vascular and functional hematopoietic readouts, single lab","pmids":["37091975"],"is_preprint":false},{"year":2024,"finding":"Nkx2.3 is a key regulator of the molecular program specifying mucous acinar cell identity in the sublingual salivary gland; Nkx2.3-/- mice show loss of mucous acinar cell gene expression program as demonstrated by RNAseq, immunostaining, and proteomic analysis of saliva.","method":"Targeted gene knockout, RNAseq, immunostaining, proteomic analysis of saliva in Nkx2.3-/- mice","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with multiple molecular readouts (transcriptomic + proteomic), single lab","pmids":["38311164"],"is_preprint":false},{"year":2024,"finding":"NKX2-3 acts upstream of PLVAP and SPARCL1 in pancreatic endothelial cells; induction of NKX2-3 in HUVECs promotes expression of PLVAP and SPARCL1, and NKX2-3 binding motifs are found in ~40% of the pancreatic EC signature genes.","method":"Gene transfection of NKX2-3 into HUVECs, RT-qPCR, single-cell RNA-sequencing data analysis, DNA-binding motif analysis","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — overexpression with direct transcriptional readout, supported by motif analysis, single lab","pmids":["39445426"],"is_preprint":false},{"year":2002,"finding":"Nkx2-3 is required for maturation and cellular organization of sublingual salivary glands, and for cusp formation in mandibular molars; loss of Nkx2-3 in null mice results in defects in these oral structures.","method":"Examination of Nkx2-3 null mice with histology and expression analysis","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined organ-specific phenotypic readout, single lab","pmids":["12141427"],"is_preprint":false}],"current_model":"NKX2-3 is a homeodomain transcription factor expressed in gut mesenchyme, visceral endothelial cells, and stromal cells that directly activates MAdCAM-1 transcription to control leukocyte homing, regulates BMP signaling in intestinal development, controls splenic vascular identity (suppressing lymph-node-like patterning) through a stromal cell-autonomous mechanism, induces B-cell receptor signaling via Lyn/Syk phosphorylation to promote marginal-zone B-cell development, drives VSMC autophagy through AMPK/mTOR activation to inhibit proliferation and migration, and acts upstream of PLVAP/BMP/p21 signaling in specialized endothelial, dental, and salivary gland cell types."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that NKX2-3 controls intestinal development non-cell-autonomously through mesenchymal BMP signaling resolved how a mesenchyme-expressed transcription factor influences epithelial proliferation.","evidence":"Targeted Nkx2-3 knockout in mice with histological and RT-PCR analysis of BMP-2/4","pmids":["10207146"],"confidence":"High","gaps":["Direct transcriptional targets in gut mesenchyme beyond BMP-2/4 not identified","Mechanism by which NKX2-3 activates BMP gene expression not resolved"]},{"year":2000,"claim":"Identifying MAdCAM-1 as a direct transcriptional target of NKX2-3 explained how this transcription factor controls leukocyte homing to mucosal tissues and spleen.","evidence":"Nkx2-3 KO mice lack MAdCAM-1; direct promoter activation assay confirmed NKX2-3 binds and activates MAdCAM-1 promoter, replicated across two independent labs","pmids":["10790368","10926756"],"confidence":"High","gaps":["Co-factors required for MAdCAM-1 activation not identified","Whether NKX2-3 is sufficient to induce MAdCAM-1 in non-endothelial contexts unknown"]},{"year":2002,"claim":"Demonstrating that Nkx2-3 loss causes salivary gland and molar cusp defects expanded the gene's developmental role beyond gut and spleen to oral structures.","evidence":"Histological examination of Nkx2-3 null mice showing sublingual gland and molar defects","pmids":["12141427"],"confidence":"Medium","gaps":["Downstream targets in salivary gland and dental tissues not identified at this stage","Mechanism linking NKX2-3 to cusp morphogenesis unknown"]},{"year":2003,"claim":"Bone marrow reconstitution experiments demonstrated that NKX2-3 functions cell-autonomously in stromal cells—not hematopoietic cells—to organize splenic architecture and support marginal-zone B cells.","evidence":"Reciprocal bone marrow transplantation in Nkx2-3−/− mice","pmids":["12682228"],"confidence":"High","gaps":["Identity of the specific stromal cell subset expressing NKX2-3 not defined","Stromal signals downstream of NKX2-3 that maintain MZ B cells not identified"]},{"year":2007,"claim":"Dissecting splenic vascular patterning revealed that NKX2-3 and LTβR signaling operate through distinct pathways—NKX2-3 controls red pulp vascular compartmentalization while LTβR controls marginal sinus maturation.","evidence":"Immunohistochemistry comparing Nkx2-3 KO, LTβR KO, and pharmacological LTβR blockade in mice","pmids":["17318587","17922052"],"confidence":"Medium","gaps":["Whether NKX2-3 and LTβR converge on shared downstream effectors not tested","Fibroblast subset identities controlled by NKX2-3 not molecularly resolved"]},{"year":2011,"claim":"Discovering that Nkx2-3 loss reprograms splenic vasculature to a lymph-node-like identity (HEVs expressing PNAd/CCL21 replacing MAdCAM-1) established NKX2-3 as a master suppressor of alternative vascular fates, with functional consequences for lymphocyte recirculation and pathogen clearance.","evidence":"mRNA profiling, immunohistochemistry, adoptive transfer, and LTβR-blocking experiments in Nkx2-3 KO mice; also detection of aberrant LYVE-1+ endothelial cysts lacking full lymphatic commitment","pmids":["21593383","21705651"],"confidence":"High","gaps":["Direct transcriptional targets mediating vascular identity suppression not identified","Whether vascular reprogramming is reversible upon NKX2-3 restoration unknown"]},{"year":2011,"claim":"NKX2-3 knockdown in human intestinal microvascular endothelial cells revealed regulation of VEGF-PI3K/AKT-eNOS and endothelin-1 pathways, and NFAT1 was identified as a regulator of NKX2-3 expression through SNP-dependent promoter binding.","evidence":"shRNA knockdown in HIMECs with microarray/RT-PCR; biotin-oligonucleotide pulldown and ChIP for NFAT1 binding at rs11190140","pmids":["21637825","21803625"],"confidence":"Medium","gaps":["Functional validation of NFAT1-NKX2-3 axis in vivo not performed","Contribution of individual downstream targets (VEGF, EDN1) to NKX2-3-dependent vascular phenotypes not dissected"]},{"year":2016,"claim":"Transgenic NKX2-3 overexpression in B cells was sufficient to drive marginal-zone expansion and lymphomagenesis through activation of BCR signaling (Lyn/Syk phosphorylation → NF-κB and PI3K-AKT), revealing an oncogenic gain-of-function mechanism distinct from its stromal role.","evidence":"Transgenic mouse model with NKX2-3 in B cells, phosphorylation assays, migration/homing assays, combined with Nkx2-3 KO analysis","pmids":["27297662"],"confidence":"High","gaps":["Whether NKX2-3 directly activates BCR pathway genes transcriptionally or acts indirectly not resolved","Relevance to human marginal-zone lymphoma not genetically confirmed"]},{"year":2018,"claim":"Placing NKX2-3 downstream of EDA/EDAR signaling and upstream of p21/BMP2/BMPR2 in enamel knot formation defined a developmental signaling cascade for tooth cusp morphogenesis.","evidence":"Microarray in mouse embryos, EDA signaling assays, immunostaining, and Nkx2-3 KO phenotyping","pmids":["30089653"],"confidence":"Medium","gaps":["Direct promoter binding of NKX2-3 at p21 or BMP2 loci not demonstrated","Whether this pathway operates in human dental development untested"]},{"year":2019,"claim":"Three advances converged: NKX2-3 was localized to VAP-1+ pericryptal stromal cells in the colon where its absence attenuates colitis; it was shown to control addressin balance in Peyer's patch HEVs; and a human loss-of-function mutation was linked to familial intestinal varices, translating the murine vascular phenotype to human disease.","evidence":"LacZ reporter, bone marrow transplantation, DSS colitis model (PMID:30700585); immunofluorescence and in vivo blocking in Peyer's patches (PMID:25320278); whole-exome sequencing with LOD 3.3 in a four-generation pedigree (PMID:31498527)","pmids":["30700585","25320278","31498527"],"confidence":"High","gaps":["Precise stromal cell-derived signals mediating colitis promotion not identified","Functional validation of the human nonsense mutation (e.g., rescue) not performed","Whether NKX2-3 variants contribute to common IBD pathogenesis mechanistically remains unclear"]},{"year":2020,"claim":"Demonstrating that NKX2-3 promotes VSMC autophagy via AMPK/mTOR to inhibit proliferation and migration extended NKX2-3 function to vascular remodeling and suggested therapeutic relevance for neointima formation.","evidence":"Adenoviral overexpression/siRNA KD in VSMCs, carotid balloon injury model, autophagy inhibitor (3-MA) rescue in vivo and in vitro","pmids":["33928642"],"confidence":"Medium","gaps":["Direct transcriptional targets linking NKX2-3 to AMPK activation not identified","Whether this mechanism operates in human vascular disease not tested"]},{"year":2023,"claim":"Revealing that Nkx2-3 loss leads to ectopic splenic lymphatic capillaries and impaired splenic erythropoiesis/megakaryopoiesis deepened the understanding of NKX2-3 as a gatekeeper of venous versus lymphatic endothelial fate in the spleen.","evidence":"Immunofluorescence, flow cytometry, qPCR, and Romiplostim stimulation in Nkx2-3 KO mice","pmids":["37091975"],"confidence":"Medium","gaps":["Whether the erythropoietic defect is secondary to vascular changes or reflects an independent stromal function unknown","Transcriptional program suppressing lymphatic commitment not defined"]},{"year":2024,"claim":"NKX2-3 was identified as a key specifier of mucous acinar cell identity in salivary glands and as a regulator of PLVAP/SPARCL1 in pancreatic endothelial cells, broadening its role as a tissue-specific transcriptional organizer of specialized cell fates.","evidence":"RNAseq and proteomics of Nkx2.3 KO salivary glands (PMID:38311164); NKX2-3 transfection in HUVECs with RT-qPCR and motif analysis (PMID:39445426)","pmids":["38311164","39445426"],"confidence":"Medium","gaps":["Direct NKX2-3 binding at mucous acinar gene promoters not confirmed by ChIP","PLVAP induction by NKX2-3 not validated in native pancreatic endothelial cells"]},{"year":null,"claim":"The genome-wide direct target repertoire of NKX2-3 remains undefined in any tissue; no ChIP-seq dataset exists, the cofactors mediating its context-dependent transcriptional activity are unknown, and its structural basis for DNA recognition specificity versus other NKX family members has not been resolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No ChIP-seq or CUT&RUN data defining direct genome-wide binding in any cell type","Cofactors or chromatin remodelers partnering with NKX2-3 not identified","Structural basis for tissue-specific target selection unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,9,21]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,8,10,12,13,18,20,21]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,9,12,13]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,8,10,13,18,20,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,13,14,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,3,6,11,12,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,12,17]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[17]}],"complexes":[],"partners":["MADCAM1","BMP2","BMP4","NFAT1","PTPN2","FLI1","PLVAP"],"other_free_text":[]},"mechanistic_narrative":"NKX2-3 is a homeodomain transcription factor that governs vascular identity, stromal organization, and organ-specific cell differentiation in the gut, spleen, and associated lymphoid tissues. It directly activates MAdCAM-1 transcription in specialized endothelial cells to control leukocyte homing via α4β7 integrin and L-selectin, and its absence causes splenic vasculature to adopt a peripheral lymph-node-like identity with ectopic high endothelial venules and aberrant lymphatic differentiation [PMID:10790368, PMID:21593383, PMID:37091975]. Functioning cell-autonomously in stromal/mesenchymal cells rather than hematopoietic cells, NKX2-3 regulates BMP-2/4 expression in gut mesenchyme to support epithelial proliferation, specifies mucous acinar cell identity in salivary glands, drives marginal-zone B-cell expansion through Lyn/Syk-dependent BCR signaling when ectopically expressed in B cells, and inhibits vascular smooth muscle cell proliferation via AMPK/mTOR-mediated autophagy [PMID:10207146, PMID:12682228, PMID:27297662, PMID:33928642, PMID:38311164]. A nonsense mutation in NKX2-3 cosegregates with familial idiopathic intestinal varices in humans [PMID:31498527]."},"prefetch_data":{"uniprot":{"accession":"Q8TAU0","full_name":"Homeobox protein Nkx-2.3","aliases":["Homeobox protein NK-2 homolog C"],"length_aa":364,"mass_kda":38.4,"function":"Transcription factor","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8TAU0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NKX2-3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NKX2-3","total_profiled":1310},"omim":[{"mim_id":"612288","title":"INFLAMMATORY BOWEL DISEASE 20; IBD20","url":"https://www.omim.org/entry/612288"},{"mim_id":"606727","title":"NK2 HOMEOBOX 3; NKX2-3","url":"https://www.omim.org/entry/606727"},{"mim_id":"102670","title":"MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1","url":"https://www.omim.org/entry/102670"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoli","reliability":"Uncertain"},{"location":"Cytosol","reliability":"Uncertain"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":35.2},{"tissue":"lymphoid tissue","ntpm":28.3},{"tissue":"salivary gland","ntpm":14.3}],"url":"https://www.proteinatlas.org/search/NKX2-3"},"hgnc":{"alias_symbol":["NKX2.3","CSX3","NKX4-3"],"prev_symbol":["NKX2C"]},"alphafold":{"accession":"Q8TAU0","domains":[{"cath_id":"1.10.10.60","chopping":"158-214","consensus_level":"high","plddt":95.2998,"start":158,"end":214}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAU0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAU0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAU0-F1-predicted_aligned_error_v6.png","plddt_mean":59.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NKX2-3","jax_strain_url":"https://www.jax.org/strain/search?query=NKX2-3"},"sequence":{"accession":"Q8TAU0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TAU0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TAU0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAU0"}},"corpus_meta":[{"pmid":"8954740","id":"PMC_8954740","title":"A new tinman-related gene, nkx2.7, anticipates the expression of nkx2.5 and nkx2.3 in zebrafish heart and pharyngeal endoderm.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8954740","citation_count":143,"is_preprint":false},{"pmid":"10207146","id":"PMC_10207146","title":"Targeted disruption of the homeobox transcription factor Nkx2-3 in mice results in postnatal lethality and abnormal development of small intestine and spleen.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10207146","citation_count":142,"is_preprint":false},{"pmid":"10790368","id":"PMC_10790368","title":"NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10790368","citation_count":78,"is_preprint":false},{"pmid":"9142493","id":"PMC_9142493","title":"The mouse Nkx2-3 homeodomain gene is expressed in gut mesenchyme during pre- and postnatal mouse development.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9142493","citation_count":59,"is_preprint":false},{"pmid":"10926756","id":"PMC_10926756","title":"Homeodomain factor Nkx2-3 controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10926756","citation_count":54,"is_preprint":false},{"pmid":"27297662","id":"PMC_27297662","title":"Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27297662","citation_count":43,"is_preprint":false},{"pmid":"12682228","id":"PMC_12682228","title":"Architectural defects in the spleens of Nkx2-3-deficient mice are intrinsic and associated with defects in both B cell maturation and T cell-dependent immune responses.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12682228","citation_count":38,"is_preprint":false},{"pmid":"12141427","id":"PMC_12141427","title":"NK-2 class homeobox genes and pharyngeal/oral patterning: Nkx2-3 is required for salivary gland and tooth morphogenesis.","date":"2002","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12141427","citation_count":36,"is_preprint":false},{"pmid":"32597755","id":"PMC_32597755","title":"Tetramerisation of the CRISPR ring nuclease Crn3/Csx3 facilitates cyclic oligoadenylate cleavage.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32597755","citation_count":31,"is_preprint":false},{"pmid":"21637825","id":"PMC_21637825","title":"NKX2-3 transcriptional regulation of endothelin-1 and VEGF signaling in human intestinal microvascular endothelial cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21637825","citation_count":25,"is_preprint":false},{"pmid":"30763319","id":"PMC_30763319","title":"BMP signaling is required for nkx2.3-positive pharyngeal pouch progenitor specification in zebrafish.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30763319","citation_count":25,"is_preprint":false},{"pmid":"21593383","id":"PMC_21593383","title":"Transcription factor Nkx2-3 controls the vascular identity and lymphocyte homing in the spleen.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21593383","citation_count":24,"is_preprint":false},{"pmid":"30089653","id":"PMC_30089653","title":"The transcription factor NKX2-3 mediates p21 expression and ectodysplasin-A signaling in the enamel knot for cusp formation in tooth development.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30089653","citation_count":24,"is_preprint":false},{"pmid":"21172269","id":"PMC_21172269","title":"Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's disease.","date":"2009","source":"Journal of Crohn's & colitis","url":"https://pubmed.ncbi.nlm.nih.gov/21172269","citation_count":24,"is_preprint":false},{"pmid":"26106927","id":"PMC_26106927","title":"Crystal structures of CRISPR-associated Csx3 reveal a manganese-dependent deadenylation exoribonuclease.","date":"2015","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/26106927","citation_count":20,"is_preprint":false},{"pmid":"20165982","id":"PMC_20165982","title":"Genes regulated by Nkx2-3 in sporadic and inflammatory bowel disease-associated colorectal cancer cell lines.","date":"2010","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20165982","citation_count":20,"is_preprint":false},{"pmid":"32826317","id":"PMC_32826317","title":"Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA4.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32826317","citation_count":19,"is_preprint":false},{"pmid":"22377701","id":"PMC_22377701","title":"PTPN2 is associated with Crohn's disease and its expression is regulated by NKX2-3.","date":"2012","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/22377701","citation_count":16,"is_preprint":false},{"pmid":"21803625","id":"PMC_21803625","title":"NKX2-3 variant rs11190140 is associated with IBD and alters binding of NFAT.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21803625","citation_count":15,"is_preprint":false},{"pmid":"33928642","id":"PMC_33928642","title":"Nkx2-3 induces autophagy inhibiting proliferation and migration of vascular smooth muscle cells via AMPK/mTOR signaling pathway.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33928642","citation_count":15,"is_preprint":false},{"pmid":"19683022","id":"PMC_19683022","title":"Lack of association of NKX2-3, IRGM, and ATG16L1 inflammatory bowel disease susceptibility variants with celiac disease.","date":"2009","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19683022","citation_count":13,"is_preprint":false},{"pmid":"20188614","id":"PMC_20188614","title":"Genes regulated by Nkx2-3 in siRNA-mediated knockdown B cells: implication of endothelin-1 in inflammatory bowel disease.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20188614","citation_count":13,"is_preprint":false},{"pmid":"26727591","id":"PMC_26727591","title":"Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily.","date":"2016","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/26727591","citation_count":12,"is_preprint":false},{"pmid":"17318587","id":"PMC_17318587","title":"Distinct roles of lymphotoxin-beta signaling and the homeodomain transcription factor Nkx2.3 in the ontogeny of endothelial compartments in spleen.","date":"2007","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/17318587","citation_count":12,"is_preprint":false},{"pmid":"24473197","id":"PMC_24473197","title":"Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24473197","citation_count":11,"is_preprint":false},{"pmid":"25320278","id":"PMC_25320278","title":"Absence of Nkx2-3 homeodomain transcription factor reprograms the endothelial addressin preference for lymphocyte homing in Peyer's patches.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25320278","citation_count":11,"is_preprint":false},{"pmid":"34768865","id":"PMC_34768865","title":"NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34768865","citation_count":11,"is_preprint":false},{"pmid":"31498527","id":"PMC_31498527","title":"Mutations in RPSA and NKX2-3 link development of the spleen and intestinal vasculature.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31498527","citation_count":11,"is_preprint":false},{"pmid":"21514341","id":"PMC_21514341","title":"Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa.","date":"2011","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21514341","citation_count":9,"is_preprint":false},{"pmid":"32859051","id":"PMC_32859051","title":"Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca2+ Influx in Nkx2-3 Knock-out Mice.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32859051","citation_count":9,"is_preprint":false},{"pmid":"21705651","id":"PMC_21705651","title":"Absence of Nkx2-3 homeodomain transcription factor induces the formation of LYVE-1-positive endothelial cysts without lymphatic commitment in the spleen.","date":"2011","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/21705651","citation_count":8,"is_preprint":false},{"pmid":"30700585","id":"PMC_30700585","title":"IL-22-Independent Protection from Colitis in the Absence of Nkx2.3 Transcription Factor in Mice.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30700585","citation_count":7,"is_preprint":false},{"pmid":"21968973","id":"PMC_21968973","title":"Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn's disease patients and possible involvement of EGR1.","date":"2012","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/21968973","citation_count":7,"is_preprint":false},{"pmid":"17922052","id":"PMC_17922052","title":"Complex organizational defects of fibroblast architecture in the mouse spleen with Nkx2.3 homeodomain deficiency.","date":"2007","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/17922052","citation_count":6,"is_preprint":false},{"pmid":"39445426","id":"PMC_39445426","title":"Single-Cell Meta-Analysis Uncovers the Pancreatic Endothelial Cell Transcriptomic Signature and Reveals a Key Role for NKX2-3 in PLVAP Expression.","date":"2024","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39445426","citation_count":5,"is_preprint":false},{"pmid":"33608382","id":"PMC_33608382","title":"Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).","date":"2021","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/33608382","citation_count":3,"is_preprint":false},{"pmid":"37091975","id":"PMC_37091975","title":"Absence of Nkx2-3 induces ectopic lymphatic endothelial differentiation associated with impaired extramedullary stress hematopoiesis in the spleen.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37091975","citation_count":2,"is_preprint":false},{"pmid":"40149732","id":"PMC_40149732","title":"Ethanol Induces Craniofacial Defects in Bmp Mutants Independent of nkx2.3 by Elevating Cranial Neural Crest Cell Apoptosis.","date":"2025","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/40149732","citation_count":2,"is_preprint":false},{"pmid":"38311164","id":"PMC_38311164","title":"Nkx2.3 transcription factor is a key regulator of mucous cell identity in salivary glands.","date":"2024","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/38311164","citation_count":1,"is_preprint":false},{"pmid":"38063211","id":"PMC_38063211","title":"Quantitative Analysis of NKX2-3 Expression in Human Colon: An Immunohistochemical Study.","date":"2023","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/38063211","citation_count":0,"is_preprint":false},{"pmid":"40416342","id":"PMC_40416342","title":"Nkx2-3 Homeobox Gene Plays an Essential Role in Later Stages of Orofacial Differentiation.","date":"2025","source":"Annals of pediatrics & child health","url":"https://pubmed.ncbi.nlm.nih.gov/40416342","citation_count":0,"is_preprint":false},{"pmid":"39803440","id":"PMC_39803440","title":"Ethanol induces craniofacial defects in Bmp mutants independent of nkx2.3 by elevating cranial neural crest cell apoptosis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39803440","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.31.630963","title":"Ethanol induces craniofacial defects in Bmp mutants independent of <i>nkx2.3</i> by elevating cranial neural crest cell apoptosis","date":"2025-01-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.31.630963","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22955,"output_tokens":5426,"usd":0.075127},"stage2":{"model":"claude-opus-4-6","input_tokens":9008,"output_tokens":3729,"usd":0.207398},"total_usd":0.282525,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Targeted inactivation of Nkx2-3 in mice causes delayed villus formation in small intestine due to reduced epithelial proliferation, and reduced BMP-2 and BMP-4 expression in gut mesenchyme, suggesting non-cell-autonomous control of intestinal cell growth through BMP signaling downstream of Nkx2-3.\",\n      \"method\": \"Targeted gene knockout in mice with histological and molecular phenotyping (RT-PCR for BMP-2/4), and observation of intestinal and splenic defects\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and molecular phenotype, replicated across multiple labs\",\n      \"pmids\": [\"10207146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NKX2-3 directly activates MAdCAM-1 transcription in spleen and mucosa-associated lymphoid tissue endothelial cells; NKX2-3-deficient mice completely lack MAdCAM-1, and this loss is responsible for the migration and homing defects of lymphocytes and macrophages.\",\n      \"method\": \"Targeted gene knockout in mice, immunohistochemistry, RT-PCR, transcriptional activation assay (direct activation of MAdCAM-1 promoter by NKX2-3)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype combined with direct promoter activation assay, replicated in independent lab (PMID:10926756)\",\n      \"pmids\": [\"10790368\", \"10926756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nkx2-3, expressed in visceral mesoderm, controls regional expression of MAdCAM-1 in specialized endothelial cells; loss of Nkx2-3 leads to down-regulation of MAdCAM-1 in endothelial cells where Nkx2-3 is normally expressed, impairing leukocyte homing via L-selectin and α4β7 integrin.\",\n      \"method\": \"Targeted gene knockout, semiquantitative RT-PCR, immunohistochemistry of MAdCAM-1 in Nkx2-3-deficient mice\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with direct molecular readout, independently replicated\",\n      \"pmids\": [\"10926756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The splenic architectural defects and absence of marginal zone B cells in Nkx2-3-deficient mice are of stromal (non-hematopoietic) origin, as shown by bone marrow reconstitution studies, establishing that Nkx2-3 functions in stromal cells to support correct lymphocyte-stroma interactions.\",\n      \"method\": \"Bone marrow reconstitution (transplantation) experiments in Nkx2-3-/- mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistatic bone marrow reconstitution directly demonstrating stromal vs hematopoietic cell-autonomous function\",\n      \"pmids\": [\"12682228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2-3 deficiency causes complex organizational defects in white pulp fibroblast subsets in the spleen, including distributional abnormalities and absence of a complementary fibroblast subpopulation, indicating Nkx2-3 controls fibroblast ontogeny in a tissue-specific manner.\",\n      \"method\": \"Immunohistochemistry and dual-label immunofluorescence in Nkx2-3-deficient mice\",\n      \"journal\": \"Pathology oncology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, immunohistochemistry without functional rescue\",\n      \"pmids\": [\"17922052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The splenic vasculature patterning is controlled by two distinct pathways: lymphotoxin-β receptor signaling controls marginal sinus maturation, while Nkx2.3 transcription factor controls vascular compartmentalization of the red pulp and marginal sinus integrity.\",\n      \"method\": \"Immunohistochemistry in Nkx2-3-deficient mice, LTβR-Ig fusion protein blockade, and genetic deletion of LTβR/RelB/p52\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple knockouts, single lab\",\n      \"pmids\": [\"17318587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In the absence of Nkx2-3, the spleen develops a peripheral lymph node-like vascular identity, including formation of high endothelial venules (HEVs) expressing PNAd addressin and CCL21, replacing MAdCAM-1; this vascular reprogramming is dependent on lymphotoxin-β receptor signaling and mature T and B cells, impairs lymphocyte recirculation and blood-borne pathogen uptake.\",\n      \"method\": \"Comparative mRNA expression profiling, immunohistochemistry, adoptive lymphocyte transfer, functional blocking experiments in Nkx2-3-deficient mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, direct functional consequence of vascular identity switch demonstrated\",\n      \"pmids\": [\"21593383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2-3 deficiency in the spleen leads to formation of LYVE-1-positive endothelial cysts without true lymphatic commitment (lacking VEGFR-3 and Prox1), indicating that Nkx2-3 normally suppresses this aberrant endothelial differentiation program.\",\n      \"method\": \"Immunohistochemistry, real-time quantitative PCR, short-term lymphocyte cell-tracing in Nkx2-3-deficient mice\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with molecular markers and functional tracing, single lab\",\n      \"pmids\": [\"21705651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NKX2-3 regulates endothelin-1 (EDN1) and VEGF-PI3K/AKT-eNOS signaling pathways in human intestinal microvascular endothelial cells (HIMECs), with NKX2-3 knockdown reducing VEGF/PI3K/AKT/eNOS expression and increasing EDN1, as validated by cDNA microarray and RT-PCR.\",\n      \"method\": \"shRNA knockdown in HIMEC lines, cDNA microarray, RT-PCR validation, pathway analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with multiple transcriptional readouts, two HIMEC lines, moderate evidence\",\n      \"pmids\": [\"21637825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NFAT1 differentially binds to the NKX2-3 promoter region containing rs11190140 SNP, with higher binding to non-methylated and methylated C allele than to T allele, as confirmed by biotin-oligonucleotide pulldown and ChIP assay, suggesting NFAT1 regulates NKX2-3 expression.\",\n      \"method\": \"Biotin-labeled oligonucleotide pulldown with nuclear extracts, Western blot, ChIP assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay and ChIP confirmation, single lab\",\n      \"pmids\": [\"21803625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NKX2-3 positively regulates PTPN2 expression in B cells and intestinal microvascular endothelial cells; NKX2-3 knockdown reduces PTPN2 mRNA, and mRNA expression of PTPN2 and NKX2-3 are positively correlated in CD patients.\",\n      \"method\": \"siRNA knockdown, cDNA microarray, RT-PCR validation in B cells and HIMECs\",\n      \"journal\": \"Disease markers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — KD with transcriptional readout, correlation confirmed in patient samples, single lab\",\n      \"pmids\": [\"22377701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nkx2-3 controls the addressin balance in high endothelial venules of Peyer's patches by maintaining MAdCAM-1 expression; in Nkx2-3-deficient mice, MAdCAM-1 is replaced by PNAd (peripheral node addressin) in an LTβR- and lymphocyte-dependent manner, while general HEV functionality for lymphocyte homing is preserved.\",\n      \"method\": \"Immunofluorescence, flow cytometry, in vivo MECA-79 blocking, quantitative PCR in Nkx2-3-deficient mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods including in vivo functional blocking, single lab\",\n      \"pmids\": [\"25320278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NKX2-3 promotes marginal-zone lymphomagenesis by inducing B-cell receptor signaling through phosphorylation of Lyn/Syk kinases, which activate integrins (LFA-1, VLA-4), adhesion molecules (ICAM-1, MAdCAM-1), and CXCR4, ultimately triggering NF-κB and PI3K-AKT pathways; transgenic NKX2-3 overexpression in B cells is sufficient to drive marginal-zone expansion and lymphoma development.\",\n      \"method\": \"Transgenic mouse model (NKX2-3 overexpression in B cells), Nkx2-3-deficient mice, phosphorylation assays, functional migration/homing assays, signaling pathway analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic overexpression + KO genetic model + biochemical signaling assays, multiple orthogonal methods\",\n      \"pmids\": [\"27297662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NKX2-3 is a target of EDA/EDAR signaling in the enamel knot; NKX2-3 mediates p21 expression, activates BMP signaling by upregulating Bmp2 and Bmpr2 in dental epithelium, and decreases SOX2 expression, establishing an EDA→NKX2-3→p21/BMP2/BMPR2 pathway required for enamel knot formation and cusp morphogenesis.\",\n      \"method\": \"Gene microarray in mouse embryos, EDA signaling assays, immunostaining, Nkx2-3-deficient mouse phenotyping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placed by microarray + KO + upstream signaling assay, single lab\",\n      \"pmids\": [\"30089653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMP2b from pharyngeal ectoderm activates Smad effectors in endodermal cells to induce nkx2.3-positive pharyngeal pouch progenitors in zebrafish; BMP signaling is required for specification of these nkx2.3+ progenitors, which give rise to the pouch epithelium.\",\n      \"method\": \"Cell lineage tracing, transgenic ablation, chemical inhibitor screen, loss-of-function analyses, Smad effector assays in zebrafish\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis and lineage tracing in zebrafish ortholog, multiple methods\",\n      \"pmids\": [\"30763319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Nkx2.3 expression is restricted to VAP-1+ myofibroblast-like pericryptal stromal cells in the colon; Nkx2.3-/- hematopoietic cells cannot rescue wild-type mice from colitis, whereas absence of Nkx2.3 in stromal cells attenuates DSS-induced colitis and enhances colonic epithelial regeneration, placing Nkx2.3 in stromal cells as a driver of colitis.\",\n      \"method\": \"LacZ-Nkx2.3 reporter mice, bone marrow transplantation rescue experiments, DSS colitis model, flow cytometry, quantitative PCR\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous localization by reporter, bone marrow rescue epistasis, direct functional colitis phenotype\",\n      \"pmids\": [\"30700585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A nonsense mutation in NKX2-3 cosegregates with familial idiopathic intestinal varices in a four-generation human pedigree (LOD score 3.3), linking NKX2-3 loss-of-function to intestinal vascular development in humans, consistent with the molecular pathway established in mice.\",\n      \"method\": \"Whole-exome sequencing, targeted Sanger sequencing, linkage analysis (LOD score)\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetics with strong LOD score linking NKX2-3 loss-of-function to vascular phenotype consistent with mouse data\",\n      \"pmids\": [\"31498527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nkx2-3 inhibits proliferation and migration of vascular smooth muscle cells (VSMCs) by promoting autophagy through activation of the AMPK/mTOR signaling pathway; autophagy inhibition with 3-MA abolished the inhibitory effects of Nkx2-3 on VSMC proliferation and migration both in vivo and in vitro.\",\n      \"method\": \"Adenovirus-mediated overexpression and siRNA knockdown, carotid balloon injury model, EdU/CCK-8 proliferation assays, scratch migration assay, fluorescent mRFP-GFP-LC3 autophagy assay, transmission electron microscopy, AMPK/mTOR pathway inhibitor rescue\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with pharmacological rescue, in vivo and in vitro, single lab\",\n      \"pmids\": [\"33928642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Aberrantly expressed NKX2-3 in a megakaryoblastic AML cell line (ELF-153) activates FLI1, a master factor for myelopoiesis driving megakaryocytic differentiation and suppressing erythroid differentiation, implicating NKX2-3 as an oncogenic driver of specific AML subtypes through FLI1 regulation.\",\n      \"method\": \"Comparative expression profiling, siRNA knockdown experiments in AML cell lines\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — siRNA KD with transcriptional readout, single lab, consistent with AML patient data\",\n      \"pmids\": [\"34768865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In the absence of Nkx2-3, the spleen develops ectopic Prox1-positive lymphatic capillaries (gp38/CD31 double-positive lymphatic endothelial cells) and loses Clever1-positive venous red pulp segments, resulting in impaired splenic erythropoiesis and severely reduced megakaryocyte colony formation after Romiplostim stimulation.\",\n      \"method\": \"Immunofluorescence, flow cytometry, quantitative PCR, pharmacological stimulation (Romiplostim/thrombopoietin-receptor mimetic) in Nkx2-3-deficient mice\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple vascular and functional hematopoietic readouts, single lab\",\n      \"pmids\": [\"37091975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nkx2.3 is a key regulator of the molecular program specifying mucous acinar cell identity in the sublingual salivary gland; Nkx2.3-/- mice show loss of mucous acinar cell gene expression program as demonstrated by RNAseq, immunostaining, and proteomic analysis of saliva.\",\n      \"method\": \"Targeted gene knockout, RNAseq, immunostaining, proteomic analysis of saliva in Nkx2.3-/- mice\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple molecular readouts (transcriptomic + proteomic), single lab\",\n      \"pmids\": [\"38311164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NKX2-3 acts upstream of PLVAP and SPARCL1 in pancreatic endothelial cells; induction of NKX2-3 in HUVECs promotes expression of PLVAP and SPARCL1, and NKX2-3 binding motifs are found in ~40% of the pancreatic EC signature genes.\",\n      \"method\": \"Gene transfection of NKX2-3 into HUVECs, RT-qPCR, single-cell RNA-sequencing data analysis, DNA-binding motif analysis\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — overexpression with direct transcriptional readout, supported by motif analysis, single lab\",\n      \"pmids\": [\"39445426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Nkx2-3 is required for maturation and cellular organization of sublingual salivary glands, and for cusp formation in mandibular molars; loss of Nkx2-3 in null mice results in defects in these oral structures.\",\n      \"method\": \"Examination of Nkx2-3 null mice with histology and expression analysis\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined organ-specific phenotypic readout, single lab\",\n      \"pmids\": [\"12141427\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NKX2-3 is a homeodomain transcription factor expressed in gut mesenchyme, visceral endothelial cells, and stromal cells that directly activates MAdCAM-1 transcription to control leukocyte homing, regulates BMP signaling in intestinal development, controls splenic vascular identity (suppressing lymph-node-like patterning) through a stromal cell-autonomous mechanism, induces B-cell receptor signaling via Lyn/Syk phosphorylation to promote marginal-zone B-cell development, drives VSMC autophagy through AMPK/mTOR activation to inhibit proliferation and migration, and acts upstream of PLVAP/BMP/p21 signaling in specialized endothelial, dental, and salivary gland cell types.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NKX2-3 is a homeodomain transcription factor that governs vascular identity, stromal organization, and organ-specific cell differentiation in the gut, spleen, and associated lymphoid tissues. It directly activates MAdCAM-1 transcription in specialized endothelial cells to control leukocyte homing via α4β7 integrin and L-selectin, and its absence causes splenic vasculature to adopt a peripheral lymph-node-like identity with ectopic high endothelial venules and aberrant lymphatic differentiation [PMID:10790368, PMID:21593383, PMID:37091975]. Functioning cell-autonomously in stromal/mesenchymal cells rather than hematopoietic cells, NKX2-3 regulates BMP-2/4 expression in gut mesenchyme to support epithelial proliferation, specifies mucous acinar cell identity in salivary glands, drives marginal-zone B-cell expansion through Lyn/Syk-dependent BCR signaling when ectopically expressed in B cells, and inhibits vascular smooth muscle cell proliferation via AMPK/mTOR-mediated autophagy [PMID:10207146, PMID:12682228, PMID:27297662, PMID:33928642, PMID:38311164]. A nonsense mutation in NKX2-3 cosegregates with familial idiopathic intestinal varices in humans [PMID:31498527].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that NKX2-3 controls intestinal development non-cell-autonomously through mesenchymal BMP signaling resolved how a mesenchyme-expressed transcription factor influences epithelial proliferation.\",\n      \"evidence\": \"Targeted Nkx2-3 knockout in mice with histological and RT-PCR analysis of BMP-2/4\",\n      \"pmids\": [\"10207146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in gut mesenchyme beyond BMP-2/4 not identified\", \"Mechanism by which NKX2-3 activates BMP gene expression not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying MAdCAM-1 as a direct transcriptional target of NKX2-3 explained how this transcription factor controls leukocyte homing to mucosal tissues and spleen.\",\n      \"evidence\": \"Nkx2-3 KO mice lack MAdCAM-1; direct promoter activation assay confirmed NKX2-3 binds and activates MAdCAM-1 promoter, replicated across two independent labs\",\n      \"pmids\": [\"10790368\", \"10926756\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-factors required for MAdCAM-1 activation not identified\", \"Whether NKX2-3 is sufficient to induce MAdCAM-1 in non-endothelial contexts unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that Nkx2-3 loss causes salivary gland and molar cusp defects expanded the gene's developmental role beyond gut and spleen to oral structures.\",\n      \"evidence\": \"Histological examination of Nkx2-3 null mice showing sublingual gland and molar defects\",\n      \"pmids\": [\"12141427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream targets in salivary gland and dental tissues not identified at this stage\", \"Mechanism linking NKX2-3 to cusp morphogenesis unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Bone marrow reconstitution experiments demonstrated that NKX2-3 functions cell-autonomously in stromal cells—not hematopoietic cells—to organize splenic architecture and support marginal-zone B cells.\",\n      \"evidence\": \"Reciprocal bone marrow transplantation in Nkx2-3−/− mice\",\n      \"pmids\": [\"12682228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific stromal cell subset expressing NKX2-3 not defined\", \"Stromal signals downstream of NKX2-3 that maintain MZ B cells not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Dissecting splenic vascular patterning revealed that NKX2-3 and LTβR signaling operate through distinct pathways—NKX2-3 controls red pulp vascular compartmentalization while LTβR controls marginal sinus maturation.\",\n      \"evidence\": \"Immunohistochemistry comparing Nkx2-3 KO, LTβR KO, and pharmacological LTβR blockade in mice\",\n      \"pmids\": [\"17318587\", \"17922052\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NKX2-3 and LTβR converge on shared downstream effectors not tested\", \"Fibroblast subset identities controlled by NKX2-3 not molecularly resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovering that Nkx2-3 loss reprograms splenic vasculature to a lymph-node-like identity (HEVs expressing PNAd/CCL21 replacing MAdCAM-1) established NKX2-3 as a master suppressor of alternative vascular fates, with functional consequences for lymphocyte recirculation and pathogen clearance.\",\n      \"evidence\": \"mRNA profiling, immunohistochemistry, adoptive transfer, and LTβR-blocking experiments in Nkx2-3 KO mice; also detection of aberrant LYVE-1+ endothelial cysts lacking full lymphatic commitment\",\n      \"pmids\": [\"21593383\", \"21705651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating vascular identity suppression not identified\", \"Whether vascular reprogramming is reversible upon NKX2-3 restoration unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"NKX2-3 knockdown in human intestinal microvascular endothelial cells revealed regulation of VEGF-PI3K/AKT-eNOS and endothelin-1 pathways, and NFAT1 was identified as a regulator of NKX2-3 expression through SNP-dependent promoter binding.\",\n      \"evidence\": \"shRNA knockdown in HIMECs with microarray/RT-PCR; biotin-oligonucleotide pulldown and ChIP for NFAT1 binding at rs11190140\",\n      \"pmids\": [\"21637825\", \"21803625\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional validation of NFAT1-NKX2-3 axis in vivo not performed\", \"Contribution of individual downstream targets (VEGF, EDN1) to NKX2-3-dependent vascular phenotypes not dissected\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Transgenic NKX2-3 overexpression in B cells was sufficient to drive marginal-zone expansion and lymphomagenesis through activation of BCR signaling (Lyn/Syk phosphorylation → NF-κB and PI3K-AKT), revealing an oncogenic gain-of-function mechanism distinct from its stromal role.\",\n      \"evidence\": \"Transgenic mouse model with NKX2-3 in B cells, phosphorylation assays, migration/homing assays, combined with Nkx2-3 KO analysis\",\n      \"pmids\": [\"27297662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-3 directly activates BCR pathway genes transcriptionally or acts indirectly not resolved\", \"Relevance to human marginal-zone lymphoma not genetically confirmed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placing NKX2-3 downstream of EDA/EDAR signaling and upstream of p21/BMP2/BMPR2 in enamel knot formation defined a developmental signaling cascade for tooth cusp morphogenesis.\",\n      \"evidence\": \"Microarray in mouse embryos, EDA signaling assays, immunostaining, and Nkx2-3 KO phenotyping\",\n      \"pmids\": [\"30089653\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding of NKX2-3 at p21 or BMP2 loci not demonstrated\", \"Whether this pathway operates in human dental development untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Three advances converged: NKX2-3 was localized to VAP-1+ pericryptal stromal cells in the colon where its absence attenuates colitis; it was shown to control addressin balance in Peyer's patch HEVs; and a human loss-of-function mutation was linked to familial intestinal varices, translating the murine vascular phenotype to human disease.\",\n      \"evidence\": \"LacZ reporter, bone marrow transplantation, DSS colitis model (PMID:30700585); immunofluorescence and in vivo blocking in Peyer's patches (PMID:25320278); whole-exome sequencing with LOD 3.3 in a four-generation pedigree (PMID:31498527)\",\n      \"pmids\": [\"30700585\", \"25320278\", \"31498527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise stromal cell-derived signals mediating colitis promotion not identified\", \"Functional validation of the human nonsense mutation (e.g., rescue) not performed\", \"Whether NKX2-3 variants contribute to common IBD pathogenesis mechanistically remains unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that NKX2-3 promotes VSMC autophagy via AMPK/mTOR to inhibit proliferation and migration extended NKX2-3 function to vascular remodeling and suggested therapeutic relevance for neointima formation.\",\n      \"evidence\": \"Adenoviral overexpression/siRNA KD in VSMCs, carotid balloon injury model, autophagy inhibitor (3-MA) rescue in vivo and in vitro\",\n      \"pmids\": [\"33928642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets linking NKX2-3 to AMPK activation not identified\", \"Whether this mechanism operates in human vascular disease not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealing that Nkx2-3 loss leads to ectopic splenic lymphatic capillaries and impaired splenic erythropoiesis/megakaryopoiesis deepened the understanding of NKX2-3 as a gatekeeper of venous versus lymphatic endothelial fate in the spleen.\",\n      \"evidence\": \"Immunofluorescence, flow cytometry, qPCR, and Romiplostim stimulation in Nkx2-3 KO mice\",\n      \"pmids\": [\"37091975\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the erythropoietic defect is secondary to vascular changes or reflects an independent stromal function unknown\", \"Transcriptional program suppressing lymphatic commitment not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"NKX2-3 was identified as a key specifier of mucous acinar cell identity in salivary glands and as a regulator of PLVAP/SPARCL1 in pancreatic endothelial cells, broadening its role as a tissue-specific transcriptional organizer of specialized cell fates.\",\n      \"evidence\": \"RNAseq and proteomics of Nkx2.3 KO salivary glands (PMID:38311164); NKX2-3 transfection in HUVECs with RT-qPCR and motif analysis (PMID:39445426)\",\n      \"pmids\": [\"38311164\", \"39445426\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct NKX2-3 binding at mucous acinar gene promoters not confirmed by ChIP\", \"PLVAP induction by NKX2-3 not validated in native pancreatic endothelial cells\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide direct target repertoire of NKX2-3 remains undefined in any tissue; no ChIP-seq dataset exists, the cofactors mediating its context-dependent transcriptional activity are unknown, and its structural basis for DNA recognition specificity versus other NKX family members has not been resolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No ChIP-seq or CUT&RUN data defining direct genome-wide binding in any cell type\", \"Cofactors or chromatin remodelers partnering with NKX2-3 not identified\", \"Structural basis for tissue-specific target selection unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 9, 21]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 8, 10, 12, 13, 18, 20, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 9, 12, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 8, 10, 13, 18, 20, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 13, 14, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 3, 6, 11, 12, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 12, 17]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MADCAM1\",\n      \"BMP2\",\n      \"BMP4\",\n      \"NFAT1\",\n      \"PTPN2\",\n      \"FLI1\",\n      \"PLVAP\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}